MedPath

Caffeine

Generic Name
Caffeine
Brand Names
Anacin, Arthriten Inflammatory Pain, Ascomp, Bc Arthritis, Bc Original Formula, Cafcit, Diurex, Dvorah, Esgic, Exaprin, Excedrin, Excedrin Tension Headache, Fioricet, Fioricet With Codeine, Fiorinal, Goody's Extra Strength, Goody's Headache Relief Shot, Goody's PM, Midol Complete, Midol Cramps & Bodyaches, Migergot, Norgesic, Norgesic Forte, Orbivan, Orphengesic, Pamprin Max Formula, Peyona, Stanback Headache Powder Reformulated Jan 2011, Trezix, Trianal, Trianal C, Triatec, Triatec-8, Vanatol, Vanatol S, Vanquish, Vivarin, Peyona (previously Nymusa), Gencebok
Drug Type
Small Molecule
Chemical Formula
C8H10N4O2
CAS Number
58-08-2
Unique Ingredient Identifier
3G6A5W338E
Background

Caffeine is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. Caffeine is similar in chemical structure to Theophylline and Theobromine. It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans. Caffeine is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.

The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999. According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely. Caffeine is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants.

Indication

Caffeine is indicated for the short term treatment of apnea of prematurity in infants and off label for the prevention and treatment of bronchopulmonary dysplasia caused by premature birth. In addition, it is indicated in combination with sodium benzoate to treat respiratory depression resulting from an overdose with CNS depressant drugs. Caffeine has a broad range of over the counter uses, and is found in energy supplements, athletic enhancement products, pain relief products, as well as cosmetic products.

Associated Conditions
Acute Pain, Chronic Lung Disease of Prematurity, Common Cold, Dyspepsia, Fatigue, Fever, Flu caused by Influenza, Headache, Menstrual Pain, Myalgia, Pain, Pain caused by Rheumatism, Primary apnea of premature newborns, Respiratory Depression, Somnolence, Tension Headache, Toothache, Under-eyes Dark Circles, Vascular Headaches, Moderate Pain
Associated Therapies
Analgesia, Antacid therapy, Athletic Performance

Examining Caffeine as a Treatment for Antidepressant-induced Arousal Dysfunction in Women

Phase 1
Completed
Conditions
Female Sexual Arousal Disorder
Interventions
Other: Placebo
First Posted Date
2023-01-17
Last Posted Date
2023-06-22
Lead Sponsor
University of Texas at Austin
Target Recruit Count
20
Registration Number
NCT05685407
Locations
🇺🇸

The University of Texas at Austin, Sexual Psychophysiology Laboratory, Austin, Texas, United States

Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia

Phase 3
Recruiting
Conditions
Bronchopulmonary Dysplasia
Interventions
Drug: Probiotic Formula
First Posted Date
2023-01-12
Last Posted Date
2023-01-12
Lead Sponsor
Tanta University
Target Recruit Count
90
Registration Number
NCT05682807
Locations
🇪🇬

Tanta University, Tanta, El Gharbia, Egypt

Drug-Drug Interaction Study Between EDP-235, Midazolam, Caffeine and Rosuvastatin in Healthy Subjects

Phase 1
Completed
Conditions
COVID-19
Interventions
First Posted Date
2022-10-26
Last Posted Date
2023-04-27
Lead Sponsor
Enanta Pharmaceuticals, Inc
Target Recruit Count
24
Registration Number
NCT05594615
Locations
🇺🇸

ICON, plc., Salt Lake City, Utah, United States

The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study

Phase 2
Recruiting
Conditions
Mild Cognitive Impairment
Postoperative Cognitive Dysfunction
Postoperative Delirium
Interventions
Drug: Dextrose Water
First Posted Date
2022-10-10
Last Posted Date
2024-03-13
Lead Sponsor
University of Michigan
Target Recruit Count
250
Registration Number
NCT05574400
Locations
🇺🇸

Michigan Medicine, Ann Arbor, Michigan, United States

The Effects of Caffeine on Heart Rate and Heart Rate Variability

Not Applicable
Conditions
Caffeine
Interventions
Drug: Placebo
First Posted Date
2022-08-30
Last Posted Date
2022-08-30
Lead Sponsor
St Mary's University College
Target Recruit Count
16
Registration Number
NCT05521386

A Study to Learn How Well a Single Dose of the Study Treatment Naproxen Sodium and Caffeine Combined in One Tablet (Fixed-dose Combination) Works to Relieve Pain After Dental Surgeries Compared to the Single Ingredients and to Placebo

Phase 3
Completed
Conditions
Postoperative Dental Pain
Interventions
First Posted Date
2022-08-03
Last Posted Date
2025-03-25
Lead Sponsor
Bayer
Target Recruit Count
541
Registration Number
NCT05485805
Locations
🇺🇸

JBR Clinical Research, Salt Lake City, Utah, United States

The Pharmacodynamics of Cannabinoid-Caffeine Combinations

Early Phase 1
Completed
Conditions
Behavioral Pharmacology of Cannabinoids
Interventions
First Posted Date
2022-07-28
Last Posted Date
2024-10-07
Lead Sponsor
Johns Hopkins University
Target Recruit Count
20
Registration Number
NCT05478863
Locations
🇺🇸

Johns Hopkins University School of Medicine BPRU, Baltimore, Maryland, United States

The Caffeine Therapy in the Fetal to Neonatal Transition

Phase 4
Recruiting
Conditions
Mechanical Ventilation Complication
Caffeine
Ventilator Lung; Newborn
Interventions
First Posted Date
2022-07-12
Last Posted Date
2025-04-02
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
50
Registration Number
NCT05454332
Locations
🇧🇷

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil

A Drug-Drug Interaction (DDI) Study of LY3437943 in Obese Participants

Phase 1
Completed
Conditions
Obesity
Interventions
First Posted Date
2022-07-06
Last Posted Date
2023-04-18
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
32
Registration Number
NCT05445232
Locations
🇺🇸

Covance Dallas, Dallas, Texas, United States

🇺🇸

Covance Clinical Research Unit, Daytona Beach, Florida, United States

Influence of Caffeine Consumption on the Human Circadian System

Not Applicable
Completed
Conditions
Caffeine
Circadian Rhythm
Caffeine Withdrawal
Sleep
Interventions
Drug: Placebo
First Posted Date
2022-06-08
Last Posted Date
2022-06-08
Lead Sponsor
Psychiatric Hospital of the University of Basel
Target Recruit Count
20
Registration Number
NCT05409339
Locations
🇨🇭

UPK Basel, Basel, Basel Stadt, Switzerland

© Copyright 2025. All Rights Reserved by MedPath